US Corporate Board Director Changes SEC Filings — August 18, 2026

18-08-2026

Columbus McKinnon Corporation held its 2026 Annual Meeting on August 14, 2026, where shareholders approved all four management proposals, including the election of 12 directors, the advisory vote on executive compensation, the ratification of Ernst & Young as auditor for FY2027, and an amendment to the 2016 Long Term Incentive Plan. All director nominees received majority support, though Aziz S. Aghili and Michael Dastoor faced notable opposition with over 1.6 million and 1.3 million votes against, respectively. The advisory vote on executive compensation also saw significant dissent with 666,321 votes against.

• · The Amendment to the LTIP was previously approved by the Board on June 1, 2026, subject to shareholder approval.
• · Ernst & Young LLP was ratified as the independent auditor for fiscal year 2027 with 44,464,798 votes for and 546,505 against, and no broker non-votes.
• · Broker non-votes totaled 4,649,911 for all director elections and Proposals 2 and 4, indicating a significant portion of shares were not voted on those items.
• · Proposal 3 (auditor ratification) had no broker non-votes, as it is considered a routine matter.

18-08-2026

Centrus Energy Corp. granted special one-time performance-based restricted stock units (Performance RSUs) to executive officers and senior leaders under a newly adopted Supplemental Executive Incentive Plan. The awards are tied to achieving milestones related to enrichment from a first cascade at its Piketon, Ohio facility, with CEO Amir V. Vexler eligible for a $5,000,000 award and other named executives receiving $2,000,000 each. The grants aim to motivate extraordinary efforts toward key company goals, but the awards are forfeited if employment terminates before vesting.

• · Performance RSUs vest upon achievement of milestones: for CEO, 100% vests on Final Milestone (enrichment from first cascade); for others, 30% vests on first cascade completion and 70% on Final Milestone, subject to cost constraints.
• · Awards are forfeited if employment terminates before vesting for any reason.
• · The 2026 Plan was adopted by the Compensation, Nominating & Governance Committee under the existing 2014 Equity Incentive Plan.
• · The award agreements will be filed as exhibits to the Form 10-Q for the quarter ending September 30, 2026.

18-08-2026

Foxx Development Holdings Inc. announced the resignation of James Liao as Chief Technology Officer, effective August 14, 2026. Mr. Liao also resigned from the same role at the company's operating subsidiary, Foxx Development Inc. The resignation was for personal reasons and was not due to any disagreement with the company's operations, policies, or practices.

• · The resignation was effective August 14, 2026.
• · Mr. Liao's departure was not due to any disagreement with the company.
• · The company's CFO, Joy Yi Hua, signed the filing.

18-08-2026

Copart, Inc. announced the addition of David J. Berger to its Board of Directors, effective August 13, 2026. Mr. Berger, 67, is a Senior Partner at Wilson Sonsini Goodrich & Rosati with extensive experience in corporate governance, M&A, and shareholder activism. This appointment strengthens the board's expertise but does not involve any financial metrics or operational changes.

• · David J. Berger has served as President of the American College of Governance Counsel since May 2023.
• · He currently serves as a director of the Long-Term Stock Exchange, where he chairs its Nominating and Governance Committee.
• · Since 2023, Mr. Berger has served as co-chair of the annual Rome Conference on AI, Ethics and Governance held at the Vatican.
• · He received his J.D. and B.A. from Duke University.
• · Copart sold more than 4 million units in the last year and operates at over 250 locations in 11 countries.

18-08-2026

Aaron Day resigned from the board of Amaze Holdings, Inc. effective August 14, 2026, with no disagreement with the company. The filing contains no financial metrics, growth data, or period-over-period comparisons.

18-08-2026

Legacy Housing Corporation appointed co-founder Kenneth E. Shipley, age 67, as Chairman and CEO effective August 13, 2026, formalizing his interim role held since October 2025. Mr. Shipley will receive a salary of $50,000 per year with no written employment agreement. The filing also discloses related-party transactions with retailers owned by a significant shareholder (Bell Mobile Homes and Shipley Bros./Crazy Red's Mobile Homes), including $4.8 million and $2.1 million in home sales for FY2025, respectively.

• · Kenneth Shipley co-founded the company in 2005 and has been a board member since January 2018.
• · He previously served as Co-CEO (Jan 2018-Feb 2019), sole CEO (Feb 2019-Jun 2022), Chairman and EVP (Jul 2022-Oct 2025), and interim CEO (Oct 10, 2025 until appointment).
• · Curtis D. Hodgson retired as Executive Chairman and board member effective July 21, 2026, as previously reported.
• · No family relationship exists between Mr. Shipley and any other director or executive officer.
• · No written employment agreement exists for Mr. Shipley; his salary is $50,000 per year with no set term.

18-08-2026

First Industrial Realty Trust, Inc. and First Industrial, L.P. filed an amendment to a prior Form 8-K to disclose the committee assignments of newly elected director Frank E. Schmitz. On August 13, 2026, the Board appointed Mr. Schmitz to the Nominating/Corporate Governance Committee and the Compensation Committee, effective upon his earlier election to the Board on June 1, 2026. This filing is a routine governance update with no financial impact.

• · The amendment was filed solely to disclose committee assignments, not to update any other disclosure.
• · Mr. Schmitz was elected to the Board effective June 1, 2026, filling a vacancy created by an increase in Board size from six to seven members.
• · The committee appointments were made on August 13, 2026, based on the recommendation of the Nominating/Corporate Governance Committee.

18-08-2026

York Water Company appointed David M. Velazquez as a new independent director, effective September 1, 2026. Mr. Velazquez brings over 40 years of utility industry experience, having previously served as President and CEO of PECO Energy and Executive Vice President at Exelon Corporation. The appointment is a routine board refreshment with no disclosed compensatory arrangements or related-party transactions.

• · Mr. Velazquez was appointed to a class of directors with terms expiring at the 2027 Annual Meeting of Shareholders.
• · He will also serve on the Board's Executive Committee.
• · No arrangement or understanding exists between Mr. Velazquez and any other person regarding his appointment.
• · No transaction between Mr. Velazquez and the Company requires disclosure under Item 404(a) of Regulation S-K.

18-08-2026

Franklin Financial Services Corp and its subsidiary, Farmers and Merchants Trust Company of Chambersburg, entered into a First Amendment to the Employment Agreement with Charles (Chad) B. Carroll, promoting him from Executive Vice President and Chief Operating Officer to President and Chief Operating Officer of the Bank. The amendment extends the employment term to a three-year evergreen period starting August 17, 2026, and enhances severance benefits, including a lump sum payment of up to 2.99 times Agreed Compensation upon a qualifying termination following a Change in Control, plus a limited gross-up for excise taxes. No financial figures or performance metrics were disclosed in this filing.

• · The amendment promotes Charles B. Carroll from Executive Vice President and COO to President and Chief Operating Officer of the Bank.
• · The employment term is now an evergreen three-year period beginning August 17, 2026, with automatic one-year extensions unless 180 days' notice is given.
• · Severance for Good Reason termination (non-Change in Control) equals remaining base salary for the Employment Period, capped between 2.00x and 2.99x annual base salary.
• · Upon a Change in Control termination, executive receives a lump sum of up to 2.99 times Agreed Compensation (highest base salary plus average of prior three years' bonuses), plus a limited gross-up for Section 280G excise taxes.
• · Post-termination benefits include continuation of life, disability, and medical insurance for up to two years.
• · The agreement includes non-solicitation and non-competition restrictions under Section 9, with an independent appraisal to value those restrictions for Section 280G purposes.

18-08-2026

On August 16, 2026, ChronoScale Holdings Corporation (formerly Ekso Bionics Holdings, Inc.) entered into an Offer of Continued Employment and a restrictive covenants agreement with CFO Jerome Wong, formalizing his role with a $400,000 base salary, a 60% target bonus, and a 300,000 RSU grant. The offer letter also includes a base salary true-up from May 5, 2026, and enhanced severance benefits tied to a change in control. The filing reflects a routine executive compensation arrangement with no negative financial metrics reported.

• · The offer letter includes a base salary true-up from May 5, 2026, to August 16, 2026, to the $400,000 level.
• · In a Qualifying CIC Termination, Mr. Wong receives nine months' salary lump sum, continued health coverage, and accelerated vesting of the initial RSU tranche.
• · In a non-Cause termination outside a CIC period, Mr. Wong receives six months' salary continuation.
• · The Covenants Agreement includes indefinite confidentiality, non-competition during employment, non-solicitation of personnel and business partners, IP assignment, and indefinite non-disparagement.

18-08-2026

GoPro, Inc. promoted Brian Tratt from Vice President, CFO to Senior Vice President, CFO effective August 14, 2026. In connection with the promotion, his annual base salary increased from $385,000 to $420,000 and his annual discretionary bonus target rose from 60% to 75% of base salary. The filing does not include any financial performance data or period-over-period comparisons.

• · Promotion effective August 14, 2026.
• · Salary increase of $35,000 (approximately 9.1% increase).
• · Bonus target increase of 15 percentage points (from 60% to 75%).

18-08-2026

On August 14, 2026, Halozyme Therapeutics elected Dannielle Appelhans to its Board of Directors, with a term ending at the 2028 annual meeting. She will receive standard non-employee director compensation under the company's existing program. No related-party transactions or special arrangements were disclosed.

• · Ms. Appelhans was not initially assigned to any Board committee.
• · Her compensation will follow the non-employee director compensation program described in the proxy statement for the 2026 Annual Meeting held on May 5, 2026.
• · No arrangements or understandings exist regarding her election, and no related-party transactions were noted.

18-08-2026

Rhinebeck Bancorp, Inc. appointed Suzanne Rhulen Loughlin to its Board of Directors effective August 18, 2026, and to the Compensation and Governance and Nominating Committees. Ms. Loughlin brings extensive experience in crisis management, insurance, and legal roles, and has served on the board of the company's subsidiary, Rhinebeck Bank, since 2011. This is a routine board appointment with no disclosed compensatory arrangements or related-party transactions.

• · Ms. Loughlin was appointed to the Compensation Committee and the Governance and Nominating Committee.
• · She is a co-founder and Executive Vice President of CrisisRisk Strategies, LLC.
• · She previously served as Chief Administrative Officer and General Counsel of a public company for two years.
• · She founded Firestorm Solutions, LLC in 2005, which was sold in 2017.
• · She was employed by Frontier Insurance Group for 15 years, holding roles including in-house counsel, Managing Attorney, and Chief Administrative Officer.
• · She has served as a director of Rhinebeck Bank since 2011 and served as a director from 2019 until December 17, 2025.
• · No arrangements or understandings exist regarding her selection as a director, and no Item 404(a) disclosures are required.

18-08-2026

Tonix Pharmaceuticals Holding Corp. appointed its President and CEO, Dr. Seth Lederman (age 69), as Interim Chief Medical Officer on August 18, 2026, in addition to his existing roles as President, CEO, and Chairman. No other arrangements, understandings, or family relationships were disclosed in connection with this appointment. The filing does not contain any financial data or period-over-period comparisons.

• · Dr. Lederman has served as President, CEO, and Chairman since October 2011.
• · Appointment effective August 18, 2026.
• · No changes to Dr. Lederman's compensation were disclosed.

18-08-2026

Levi Strauss & Co. announced the retirement of Director Robert Eckert effective August 14, 2026, due to the company's mandatory retirement age of 72. Eckert had served on the board since 2010 and recently stepped down as Board Chair in April 2026. The board appointed Joshua Prime as the new chair of the Nominating, Governance and Corporate Citizenship Committee, and reduced the board size to ten directors.

• · Robert Eckert served as Board Chair until April 2026.
• · Eckert was a member of the Compensation and Human Capital Committee.
• · The retirement is not the result of any disagreement with the company.
• · The board size was reduced from an unreported prior number to ten directors.

18-08-2026

nVent Electric plc filed an 8-K on August 18, 2026, announcing that Randolph A. Wacker, who had previously announced his retirement effective September 1, 2026, has decided to stay with the Company and will continue to serve as Senior Vice President and Chief Accounting Officer. The Board appointed Mr. Wacker to this role effective September 1, 2026, and Tyler Krutzig will continue in his current role as Assistant Corporate Controller. This filing does not contain any financial data or period-over-period comparisons.

• · The filing is under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers).
• · Mr. Wacker's retirement was previously disclosed in an 8-K filed on June 17, 2026.
• · The Board appointed Mr. Wacker to the role on August 14, 2026, effective September 1, 2026.

18-08-2026

Duos Technologies Group, Inc. appointed Dipan Patel as Chief Operating Officer on August 14, 2026. Mr. Patel brings extensive experience scaling digital infrastructure businesses globally, having previously directed Telstra InfraCo's $25 billion portfolio and served as EVP at SBA Communications. He will receive an annual base salary of $375,000 with a potential bonus of up to 80% of base salary, plus 200,000 restricted shares vesting on July 1, 2029.

• · Mr. Patel joined Duos Technologies in June 2026, two months before his appointment as COO.
• · The restricted stock grant vests on a three-year cliff basis on July 1, 2029.
• · Mr. Patel holds a PhD in Intelligent and Interactive Systems from the University of London.
• · No family relationships exist between Mr. Patel and any director or executive officer.
• · No material transactions involving Mr. Patel require disclosure under Item 404(a).

18-08-2026

Brighthouse Financial announced the appointment of Richard A. Cook as Chief Accounting Officer, effective September 3, 2026, succeeding Melissa B. Pavlovich, who is resigning to pursue a new opportunity. Mr. Cook will receive an annual base salary of $425,000, a target short-term incentive of 60% of base salary, and a long-term incentive target of $219,500. The departure is not related to any financial statement or accounting issues.

• · Richard A. Cook, age 50, joined Brighthouse Financial in 2016 as Investment Controller and served as Interim CAO from November 2024 to August 2025.
• · Prior to Brighthouse, Cook was Assistant Vice President, Regulatory Reporting at MetLife, Inc. since 2010, and began his career at State Street Bank & Trust and AEGON Equity Group.
• · Melissa B. Pavlovich's resignation is effective September 2, 2026, and is not due to any disagreements on financial statements or accounting practices.

18-08-2026

Kennametal Inc. announced the election of Dawne S. Hickton and Richard J. Harshman to its Board of Directors, effective immediately. Hickton brings deep expertise in additive manufacturing and aerospace/defense, while Harshman contributes extensive executive leadership and financial governance experience from ATI and other public boards. The appointments strengthen the board's strategic, operational, and financial capabilities to support long-term shareholder value.

• · Hickton holds a Bachelor of Arts from the University of Rochester and a Juris Doctor from the University of Pittsburgh.
• · Harshman holds a BSBA in Accounting from Robert Morris University and a Certified Public Accounting certificate from the California State Board of Accountancy.
• · Harshman currently chairs the Audit Committee at PNC Financial Services Group and the Audit and Risk Committee at Ameren Corporation.
• · Hickton chairs the Board of Directors at Elevra Lithium.
• · Kennametal serves customers in nearly 100 countries.

18-08-2026

Cocrystal Pharma, Inc. appointed Carol L. Brosgart as a director effective August 12, 2026. The filing contains no financial results or performance metrics, only a routine board appointment with no disclosed arrangements, family relationships, or related-party transactions.

18-08-2026

On August 17, 2026, Scott Carlston resigned as CFO of Transglobal Management Group, Inc. (TMGI) effective immediately. The resignation was not due to any disagreement with the company regarding operations, policies, or practices. No successor or interim CFO has been announced.

• · Resignation effective immediately on August 17, 2026
• · No disagreement cited as reason for departure
• · No successor or interim CFO named in the filing

18-08-2026

Legence Corp. appointed Robert Crisci as a new Class II director, expanding the board from six to seven members. Mr. Crisci brings extensive public company CFO experience, having served as CFO of Lineage, Inc. and Roper Technologies. He will receive standard non-management director compensation including an $85,000 annual cash retainer and approximately $150,000 in restricted stock units.

• · Mr. Crisci will serve on the Audit Committee and Nomination and Corporate Governance Committee.
• · His initial term expires at the annual meeting of shareholders in 2027.
• · He holds a BA in Economics from Princeton University and an MBA from Columbia Business School.
• · The Board determined Mr. Crisci meets Nasdaq independence requirements.
• · He has entered into the company's standard form of indemnity agreement.

18-08-2026

Catalyst Bancorp, Inc. entered into a new three-year employment agreement with President and CEO Joseph B. Zanco, effective August 17, 2026, with a base salary of $350,000 and eligibility for stock-based compensation. The agreement includes severance provisions: 12 months of base salary for involuntary termination without cause or for good reason, and 36 months of base salary if termination occurs in connection with a change in control. No financial results or period-over-period comparisons are included in this filing.

• · The employment agreement expires on August 17, 2029, unless renewed or extended.
• · Mr. Zanco is eligible for the maximum allocation allowed for stock options and restricted stock awards under established stock-based benefit plans (currently 25% of stock compensation pools).
• · Severance payments are contingent upon Mr. Zanco executing a release of claims against Catalyst Bank or its affiliates.
• · The agreement is terminable with or without cause by Catalyst Bank; Mr. Zanco has no right to compensation after termination for cause except for vested and earned benefits.

18-08-2026

Nano Dimension Ltd. appointed Nadav Kidron as an independent Class II director, effective August 16, 2026, to serve on the Audit and Compensation Committees. Separately, the 30-day exclusivity period under a non-binding term sheet with Infinite Epigenetics, Inc. expired on July 15, 2026, and no definitive agreement has been reached.

• · Nadav Kidron has served as President, CEO and a director of Oramed Pharmaceuticals since March 2006, and as Chairman since June 2022.
• · Mr. Kidron also serves on the boards of Lifeward Ltd. (since March 2026), Oravax Medical Inc. (Chairman, since March 2021), Alpha Tau Medical Ltd. (since May 2025), and MDG Real Estate Global Ltd. (Chairman, since July 2024).
• · The exclusivity period with Infinite Epigenetics, Inc. expired on July 15, 2026, and no definitive agreement has been reached as of the filing date.

18-08-2026

Privia Health Group, Inc. announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026. Dr. Ernest brings over 20 years of healthcare executive experience, including her current role as President of HCSC Markets at Health Care Service Corporation. The appointment is a routine board addition with no financial impact disclosed.

• · Dr. Ernest has been named a member of the Compliance Committee of the Board.
• · Dr. Ernest has served as President, HCSC Markets at Health Care Service Corporation since 2023.
• · She served as Executive Vice President, Chief Operating Officer at HCSC from 2021 to 2023.
• · Dr. Ernest is a board-certified family physician with a degree in medicine from The Ohio State University College of Medicine and a bachelor's degree from the University of Michigan.
• · Privia Health has a presence in 25 states and the District of Columbia.

18-08-2026

Xylem Inc. (NYSE: XYL) appointed Andrea van der Berg as Executive Vice President and Chief Financial Officer, effective September 1, 2026, succeeding William "Bill" Grogan, who is departing for another opportunity. Van der Berg brings over 20 years of finance experience, including 13 years at Honeywell and leadership of Xylem's Water Infrastructure segment's finance function. The company reaffirmed its Q3 and full-year 2026 guidance, signaling no immediate change in financial outlook.

• · Van der Berg currently serves as Senior Vice President, Finance of Xylem's Water Infrastructure segment.
• · Grogan will remain with Xylem through mid-September to support the transition.
• · Xylem reaffirmed its Q3 2026 and full-year 2026 guidance issued on July 28, 2026.
• · Xylem's revenue in 2025 was $9 billion with approximately 22,000 employees.

18-08-2026

GE HealthCare announced the appointment of William (Bill) Grogan as Chief Financial Officer, effective September 14, 2026, succeeding Jay Saccaro, who stepped down for a role outside the medical technology industry. Grogan joins from Xylem Inc., where he served as EVP and CFO since 2023, and previously held CFO roles at IDEX Corporation. The appointment is part of GE HealthCare's leadership transition, with interim CFO George Newcomb continuing as Controller and Chief Accounting Officer.

• · Grogan served as CFO at Xylem since 2023 and at IDEX from 2017 to 2023.
• · At Xylem, Grogan integrated a $7.5 billion acquisition and delivered cost synergies ahead of schedule.
• · At IDEX, Grogan helped reposition the portfolio toward higher-growth markets, supporting a more than doubling of market capitalization.
• · Grogan holds an MBA from Northwestern University's Kellogg School of Management and a bachelor's degree in finance from Merrimack College.
• · Grogan serves on the Board of Directors and Audit Committee of Crane NXT and on the Advisory Council for the Girard School of Business at Merrimack College.

18-08-2026

Oglethorpe Power Corp. provided a Q2 2026 investor briefing highlighting a massive $6.6–7.2 billion new generation construction program through 2033, including the Smarr CC (1,425 MW, $3.3B) and Talbot CT (240 MW, $440M) projects. The company received a conditional RUS commitment for the $3.3B Smarr CC loan on August 6, 2026, and closed a $302.18M New ERA refinancing for stranded Wansley coal plant debt. However, total sales to members were nearly flat (+0.9% YoY) for the six months ended June 30, 2026, with capacity sales declining 2.2% and energy sales to members (MWh) falling 0.8%, while net margin grew only 0.7% to $64.4M.

• · Net plant in service decreased slightly from $12,032M (Dec 2025) to $11,970M (Jun 2026), a decline of 0.5%.
• · Construction work in progress (CWIP) surged 45.5% from $788M (Dec 2025) to $1,147M (Jun 2026).
• · Total long-term debt and finance leases remained nearly flat at $12,097M (Jun 2026) vs $12,087M (Dec 2025).
• · The equity ratio improved to 10.3% (Jun 2026) from 9.9% (Dec 2025) and 9.5% (Dec 2024).
• · Margins for Interest ratio was 1.10 for both six-month periods, meeting the minimum Indenture requirement.
• · Average power cost increased 1.7% YoY to 8.33 cents/kWh (6 months ended Jun 2026).
• · Sales to members energy cost rose 7.7% YoY to 3.01 cents/kWh.
• · The company expects to spend ~$2B on the existing fleet over the next 5 years in addition to the $6.6–7.2B new generation program.
• · Talbot 7 CT budget was re-baselined and completed at $440M; general contractor selection is pending.
• · Battery storage project is in RFP process with evaluation expected in Fall 2026.
• · The 2032 New CT and 2033 New CC were approved and fully subscribed by members in Q2 2026.
• · Walton CT remains under partial deferral through December 31, 2027.
• · RUS loan for Smarr CC ($3,324M) was conditionally committed on August 6, 2026, with initial funding expected by 2028.
• · Two RUS loans for general capital improvements totaling $599M were conditionally committed but not yet funded.
• · The company is discussing amendment and extension of its $1.275B syndicated bank credit facility.
• · Total current liabilities increased from $1,435M (Dec 2025) to $1,579M (Jun 2026).